Dec 01, 2021 / 04:45PM GMT
Joshua Elliott Schimmer - Evercore ISI Institutional Equities, Research Division - Senior MD & Equity Analyst
All right. Welcome, everyone. It's Josh Schimmer from the Evercore ISI biotech team. Pleased to introduce from Exelixis we have Chris Senner, Chief Financial Officer; and Andrew Peters, Senior Vice President of Strategies. Gentlemen, welcome, thanks for joining.
Questions and Answers:
Joshua Elliott Schimmer - Evercore ISI Institutional Equities, Research Division - Senior MD & Equity AnalystCabo just keeps growing. It's now north of annualizing north of $1 billion. Maybe talk to us a little bit about the primary growth drivers and how sustainable those growth drivers are? And then we'll get into some of the newer emerging growth drivers.
Christopher J. Senner - Exelixis, Inc. - Executive VP & CFO
All right. Josh, thanks for having us here, and thanks for the invitation to the conference. Before I get started, just a couple of comments around risk factors and forward-looking statements. So
Trustpilot
